The empirical evidence suggests that stock returns in the emerging technology environment
exhibit high stock return volatility. The fundamental aim of the article is to investigate the …

Despite very strong differences in their treatment of technological change in economic
theory, both the neoclassical and the Schumpeterian evolutionary economic approaches …

Success in pharmaceutical clinical development requires organizational management
capabilities.“Entrepreneurial Orientation (EO)” is a strategic construct that reflects the extent …

If market 'selection'works, and if innovation leads to greater efficiency (higher quality and/or
lower costs), then one should expect to find a relationship between innovation and firm …

In modern information economies, economic success increasingly depends on the ability to
apply knowledge and to transform it into firm value. While intellectual capital plays a critical …

Novelty is widely acknowledged to be key in the growth and prosperity of firms. However, the
multifaceted and complex characteristics that govern novelty processes can also link it to …

The objective of this study is to evaluate the effect of intangible assets intensity on the
volatility of stock prices for firms listed at the Nairobi Securities Exchange. The study checks …

This Dissertation investigates the relationship between patent quality and company
performance for a sample from the US Biotechnology and Pharmaceutical Industry. The …

In this paper we offer an alternative framework for examining why risk matters in the
decisions of economic agents, and how the agent's risk attitude affects his decisions. This …

概 要製薬企業の臨床開発において, 製造販売承認を取得し, 上市に至る割合は 9.6% に過ぎない.
一般に製薬企業の創薬開発力においては, 上流と下流で影響を与える要因が大きく異なっている …